p of 33.9% Diabetes value market leadership expansion driven by the GLP-1 franchise Novo Nordisk ® Diabetes care sales grew by 21% (CER) with global value market share increase driven by market share gains in both IO and NAO. • Global diabetes value market share increased by 0.6%-points to 33.9% compared to last year • Exceeded strategic aspiration for 2025 by achieving a global diabetes market value of more than 1/3 • Novo Nordisk continues to be the global market leader in the GLP-1 segment with a 55.6% value market share • Estimated global GLP-1 share of total diabetes prescriptions is 6.4% prices
Download PDF file